Anixa Biosciences, Inc. (ANIX) vs Cognition Therapeutics, Inc. (CGTX)
A side-by-side comparison of Anixa Biosciences, Inc. and Cognition Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.05HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT
CGTX
Cognition Therapeutics, Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 11:43 AM EDT
Total return — ANIX vs CGTX
growth of $100 · dividends reinvested · last 5yANIX -38.2% (-9.2%/yr)CGTX -92.7% (-40.7%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX CGTX
ANIX vs CGTX: by the numbers
- •ANIX is the larger company ($104M vs $85M market cap).
Metrics side by side
Valuation
| Metric | ANIX | CGTX |
|---|---|---|
| P/B ratio | 7.16 | 2.57 |
Profitability
| Metric | ANIX | CGTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -72.02% | -50.80% |
| ROIC | -82.35% | -109.43% |
Growth (annualized)
| Metric | ANIX | CGTX |
|---|---|---|
| Total return CAGR (5Y) | -8.26% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.